“…A-051, 2004). We investigated the activities of daptomycin against Bacillus cereus and other Bacillus species since these organisms are increasingly being implicated in gastrointestinal disease and various other serious infections, such as bacteremia (2,4,13,14,16), meningitis (5,13), pneumonia (12), endophthalmitis (11,20), periodontitis (15), and other infections (1,9,10,17,18,21), especially in immunocompromised patients.…”